logo
Plus   Neg
Share
Email

Dollar General Updates FY17 Guidance - Quick Facts

Dollar General Corp. (DG) narrowed its fiscal 2017 GAAP earnings per share guidance to a range of $4.37 to $4.47, compared to its prior guidance range of $4.35 to $4.50. The company said its current earnings per share guidance range includes the estimated net negative impact on the third-quarter earnings per share results of $0.05 related to the hurricanes.

The company now forecasts: fiscal 2017 net sales growth of approximately seven percent, compared to its prior guidance range of five to seven percent growth.
Fiscal 2017 same-store sales growth is expected to be approximately 2.5 percent, compared to its prior expectation that same-store sales would fall at the upper end of the range of slightly positive to up two percent.

Third-quarter net income was $253 million, or $0.93 per share compared to $235 million, or $0.84 per share, prior year. An estimated $0.05 hurricane-related net negative impact, driven by hurricane-related expenses, is included in earnings per share for the 2017 third quarter.

Third-quarter net sales increased 11.0 percent to $5.90 billion compared to $5.32 billion, previous year. Same-store sales increased 4.3 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. has filed a lawsuit against Amazon.com Inc., accusing its e-commerce rival of illegally poaching sellers on its marketplace by infiltrating eBay's internal messaging system. The lawsuit filed by eBay on Wednesday in Santa Clara County in California, accuses Amazon of having "perpetrated a scheme to infiltrate and exploit eBay's internal member email system" over the past several years. Philip Morris International Inc. (PM) announced, for the third-quarter, reported and adjusted diluted earnings per share was $1.44, up 13.4% versus $1.27 in 2017. Excluding unfavorable currency of $0.09, adjusted diluted earnings per share up by 20.5% to $1.53 from $1.27 in 2017. On average, 13 analysts... Shares of Novartis AG were gaining around 2 percent in the morning trading in Switzerland after the drug major on Thursday lifted its fiscal 2018 net sales guidance, despite weak profit in its third quarter. Core earnings topped analysts' estimates, while net sales missed their view, despite a growth. Further, Novartis announced an agreement to buy Endocyte, a US-based biopharmaceutical company.
Follow RTT